Pharmabiz

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production: Shardul Nautiyal, Mumbai Tuesday, June 30, 2026, 08:00 Hrs [IST] ...
Pharmabiz

Medical professionals harness AI to streamline healthcare tasks, creating more time for patient care

Medical professionals harness AI to streamline healthcare tasks, creating more time for patient care: Nandita Vijayasimha, Bengaluru Tuesday, June 30, 2026, 08:00 Hrs [IST] Health ...
Pharmabiz

DoP invites application from experts to operate as technical consultants and YPs

DoP invites application from experts to operate as technical consultants and YPs: Gireesh Babu, New Delhi Tuesday, June 30, 2026, 08:00 Hrs [IST] The Department of Pharmaceuticals ...
Pharmabiz

India leads in pharma manufacturing but lags in digital infrastructure

India leads in pharma manufacturing but lags in digital infrastructure: Nandita Vijayasimha, Bengaluru Tuesday, June 30, 2026, 08:00 Hrs [IST] India is the largest supplier of gen ...
Pharmabiz

Medical devices industry seeks govt support to reduce import dependence

Medical devices industry seeks govt support to reduce import dependence: Gireesh Babu, New Delhi Tuesday, June 30, 2026, 08:00 Hrs [IST] The medical devices industry in the countr ...
Pharmabiz

J&J presents new Imaavy data at EAN 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

J&J presents new Imaavy data at EAN 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis: Geneva Monday, June 29, 2026, 18:00 Hrs [IST] Johnson & J ...
Pharmabiz

EMA committee recommends approval of AstraZeneca & Daiichi Sankyo’s Datroway for 1st-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy

EMA committee recommends approval of AstraZeneca & Daiichi Sankyo’s Datroway for 1st-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy: C ...
Pharmabiz

EMA committee recommends marketing approval for Acadia Pharma’s Daybu to treat neurobehavioral symptoms of Rett syndrome

EMA committee recommends marketing approval for Acadia Pharma’s Daybu to treat neurobehavioral symptoms of Rett syndrome: San Diego Monday, June 29, 2026, 17:00 Hrs [IST] Acadia ...
Pharmabiz

US FDA proposes rule that would help hold foreign tobacco product manufacturers accountable, protect public health

US FDA proposes rule that would help hold foreign tobacco product manufacturers accountable, protect public health: Silver Spring, Maryland Monday, June 29, 2026, 14:00 Hrs [IST] ...
Pharmabiz

Dr GSK Velu conferred with Lifetime Achievement award for contributions to healthcare and industry leadership

Dr GSK Velu conferred with Lifetime Achievement award for contributions to healthcare and industry leadership: Our Bureau, Mumbai Monday, June 29, 2026, 12:12 Hrs [IST] Dr GSK Vel ...
Pharmabiz

Alembic Pharma receives US FDA final approval for Dapsone Gel

Alembic Pharma receives US FDA final approval for Dapsone Gel: Our Bureau, Mumbai Monday, June 29, 2026, 13:30 Hrs [IST] Alembic Pharmaceuticals Limited announced that it has rece ...
Pharmabiz

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...